Alpa Laboratories Ltd
Thu 13/03/2025,15:43:59 | NSE : ALPA
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 104.30
Previous Close
₹ 103.52
Volume
29615
Mkt Cap ( Rs. Cr)
₹224.40
High
₹ 108.59
Low
₹ 104.30
52 Week High
₹ 144.50
52 Week Low
₹ 69.90
Book Value Per Share
₹ 78.24
Dividend Yield
0.00
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Alpa Laboratories Ltd
Your Vote -
Buy
68.75%
Hold
12.50%
Sell
18.75%
68.75%
32 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Alpa Laboratories Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Alpa Laboratories Lt - Clarification - Financial Results
-
Alpa Laboratories Lt - Integrated Filing- Financial
-
Alpa Laboratories Lt - Integrated Filing (Financial)
-
Alpa Laboratories Lt - General Updates
-
Alpa Laboratories Lt - Change In Designation Of Mr. Vitthal Kothana (DIN- 09489318) From Non-Executive Director To Executive
-
Alpa Laboratories Lt - Financial Result Updates
-
Alpa Laboratories Lt - Appointment of Company Secretary and Compliance Officer
-
Alpa Laboratories Lt - Updates
-
Alpa Laboratories Lt - Outcome of Board Meeting
-
Alpa Laboratories Lt Q3 net profit jumps 96.25% at Rs 8.89 cr
-
Alpa Laboratories Lt - Financial Results For The Quarter Ended December, 2024
-
Alpa Laboratories Lt - Disclosure of material issue
-
Alpa Laboratories Lt - Announcement under Regulation 30 (LODR)-Acquisition
-
Alpa Laboratories Lt - Board Meeting Intimation
-
Alpa Laboratories Lt - Board Meeting Intimation for To Approve The Standalone And Consolidated Unaudited Financial Results Fo
-
Alpa Laboratories Lt has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024
-
Alpa Laboratories Lt - Trading Window
-
Alpa Laboratories Lt - Trading Window-XBRL
Key fundamentals
Evaluate the intrinsic value of Alpa Laboratories Ltd stock
Name | March-24 | March-23 | March-22 | March-21 | March-20 |
---|---|---|---|---|---|
Assets | 167.2191 | 147.1215 | 137.4871 | 117.5297 | 110.4216 |
Liabilities | 167.2191 | 147.1215 | 137.4871 | 117.5297 | 110.4216 |
Equity | 21.0406 | 21.0406 | 21.0406 | 21.0406 | 21.0406 |
Gross Profit | 8.1447 | 8.0761 | 10.6864 | 7.7085 | 3.452 |
Net Profit | 16.7777 | 12.6243 | 14.1258 | 7.2644 | 4.0781 |
Cash From Operating Activities | 3.6991 | 8.8196 | 2.2041 | -1.4511 | 17.6568 |
NPM(%) | 15.42 | 13.58 | 12.58 | 7.44 | 4.74 |
Revenue | 108.7391 | 92.9552 | 112.2664 | 97.554 | 85.9691 |
Expenses | 100.5944 | 84.8791 | 101.58 | 89.8455 | 82.5171 |
ROE(%) | 10.19 | 7.66 | 8.58 | 4.41 | 2.47 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|
Peers
Other companies within the same industry or sector that are comparable to Alpa Laboratories Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 808.20 | -1.14 | 11.41 | 60.58 | 1321.50 | 1.42 |
Lotus Eye Hospital and Institute Ltd | 57.06 | -0.77 | 237.75 | 220.75 | 14.01 | 0.88 |
Vaishali Pharma Ltd | 12.12 | -5.90 | 606.00 | 113.78 | 2.31 | 0.00 |
Astec Lifesciences Ltd | 653.90 | -5.55 | 0.00 | 208.15 | -239.30 | 0.00 |
Company Info
Mr. Purushottam R. Patel, Mr. M.S. Chawla and Mr. Pravin C. Shah, partners of M/s Alpa Laboratories, which was formed in the year 1967, incorporated a private limited company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In the year 1998, Alpa Laboratories Private Limited was converted into a public limited company with effect from September 3, 1998 with the name of "Alpa Laboratories Limited". In the year 1997, we initiated setting of a new manufacturing unit at 33/2, Pigdamber, A.B. Road, Rau, District Indore, Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. We manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark "Alpa" which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. We also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, we also undertake contract manufacturing of a large variety of pharmaceuticals. We manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. We have an established product-marketing network covering both metro and mini metro cities, which enable us to reach our existing and potential customers through our network of distributors and dealers spread across the country. For the purpose of marketing the various products, our Company's business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division. HISTORY AND MAJOR EVENTS 1988 Incorporation of Alpa Laboratories Private Limited 1997 Commenced setting up of manufacturing facility at Pigdamber, Indore 1998 Conversion to Alpa Laboratories Limited, a public limited company 1999 Start of commercial production 2001 WHO GMP Certification for its manufacturing facilities Entered into an agreement for Contract manufacturing at its newly constructed facility, with Plethico Pharmaceuticals Ltd., a Pharmaceutical company, for manufacturing its various range of products. The manufacturing facilities at Pigdamber were certified as WHO GMP compliant by SGS-ICS Belgium for the period 2001-02. 2003 Certified ISO 9001: 2000* The manufacturing facility at Pigdamber was approved by the Director General of Quality Assurance (DGQA), India thereby opening its doors for participating in Tenders for supplies to defence institutions** Started export of its Veterinary products and registered its 7 veterinary products in Sudan 2006 Started participation in international tenders for export in addition to domestic marketing abroad and won a major tender from CMS, Sudan. Launched Veterinary Division with a new face and ethical promotion of its Veterinary products launched in 5 states in the year 2006. Launched Ethical division for its human products * Expired on May 14, 2006 ** Expired on January 22, 2006. This certificate is not required now as our revenue have crossed Rs 2000.00 lakhs as per DGQA norms. 2007 -Alpa Laboratories ties up with Vhermann Pharmaceutical Inc, Philippines for distribution of its products. 2010 - The Company has recommended dividend of 10%. 2014 - Ms. Monali Patel, Member of The Institute of Company Secretaries of India (ICSI) has been appointed as the Company Secretary and Compliance Officer. - Alpa Laboratories has sold its Unit-II ("Undertaking) situated at Sector III, Pithampur, Dhar (M.P.) as a going concern on a slump sale basis to Ipca Laboratories Limited. 2015 -Alpa Laboratories Ltd has formed a wholly owned subsidiary under the name and style of Norfolk Mercantile Private Ltd.
Mr. Purushottam R. Patel, Mr. M.S. Chawla and Mr. Pravin C. Shah, partners of M/s Alpa Laboratories, which was formed in the year 1967, incorporated a private limited company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In the year 1998, Alpa Laboratories Private Limited was converted into a public limited company with effect from September 3, 1998 with the name of "Alpa Laboratories Limited". In the year 1997, we initiated setting of a new manufacturing unit at 33/2, Pigdamber, A.B. Road, Rau, District Indore, Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. We manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark "Alpa" which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. We also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, we also undertake contract manufacturing of a large variety of pharmaceuticals. We manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. We have an established product-marketing network covering both metro and mini metro cities, which enable us to reach our existing and potential customers through our network of distributors and dealers spread across the country. For the purpose of marketing the various products, our Company's business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division. HISTORY AND MAJOR EVENTS 1988 Incorporation of Alpa Laboratories Private Limited 1997 Commenced setting up of manufacturing facility at Pigdamber, Indore 1998 Conversion to Alpa Laboratories Limited, a public limited company 1999 Start of commercial production 2001 WHO GMP Certification for its manufacturing facilities Entered into an agreement for Contract manufacturing at its newly constructed facility, with Plethico Pharmaceuticals Ltd., a Pharmaceutical company, for manufacturing its various range of products. The manufacturing facilities at Pigdamber were certified as WHO GMP compliant by SGS-ICS Belgium for the period 2001-02. 2003 Certified ISO 9001: 2000* The manufacturing facility at Pigdamber was approved by the Director General of Quality Assurance (DGQA), India thereby opening its doors for participating in Tenders for supplies to defence institutions** Started export of its Veterinary products and registered its 7 veterinary products in Sudan 2006 Started participation in international tenders for export in addition to domestic marketing abroad and won a major tender from CMS, Sudan. Launched Veterinary Division with a new face and ethical promotion of its Veterinary products launched in 5 states in the year 2006. Launched Ethical division for its human products * Expired on May 14, 2006 ** Expired on January 22, 2006. This certificate is not required now as our revenue have crossed Rs 2000.00 lakhs as per DGQA norms. 2007 -Alpa Laboratories ties up with Vhermann Pharmaceutical Inc, Philippines for distribution of its products. 2010 - The Company has recommended dividend of 10%. 2014 - Ms. Monali Patel, Member of The Institute of Company Secretaries of India (ICSI) has been appointed as the Company Secretary and Compliance Officer. - Alpa Laboratories has sold its Unit-II ("Undertaking) situated at Sector III, Pithampur, Dhar (M.P.) as a going concern on a slump sale basis to Ipca Laboratories Limited. 2015 -Alpa Laboratories Ltd has formed a wholly owned subsidiary under the name and style of Norfolk Mercantile Private Ltd.
Read More
Parent Organisation
Alpa Laboratories Ltd.
Founded
18/03/1988
Managing Director
Mr.Paresh Chawla
NSE Symbol
ALPAEQ
FAQ
The current price of Alpa Laboratories Ltd is ₹ 106.65.
The 52-week high for Alpa Laboratories Ltd is ₹ 108.59 and the 52-week low is ₹ 104.30.
The market capitalization of Alpa Laboratories Ltd is currently ₹ 224.40. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Alpa Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Alpa Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Alpa Laboratories Ltd shares.
The CEO of Alpa Laboratories Ltd is Mr.Paresh Chawla, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.